4 years of validation experience in a diagnostic, medical device, biotech or pharmaceutical company. Experience with electronic document management systems….
From Hologic – 28 Aug 2015 22:18:36 GMT
– View all San Diego jobs
Top three skills: Buffer/reagent preparation, wash glassware, lab support
1. Responsible for preparation and documentation of reagents.
2. Responsible for general lab safety with regard to employees and clients.
3. Fill pipette t […
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2015 /PRNewswire/ — CytomX Therapeutics, Inc., a biopharmaceutical company developing Probody™ therapeutics for the treatment of cancer, today announced the filing of a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of its common stock. The number of shares to be offered and the price range for the offering have not yet been determined. CytomX intends to list its common stock under the symbol “CTMX” on the NASDAQ Global Market.
BofA Merrill Lynch, Jefferies LLC and Cowen and Company LLC will act as joint book-running managers for the offering. Oppenheimer & Co. will serve as manager for the offering.
A registration statement relating to these securities has been filed with the SEC, but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
The offering will be made only by means of a prospectus. When available, copies of the preliminary prospectus relating to the offering may be obtained from BofA Merrill Lynch, 222 Broadway, New York, NY 10038, Attention: Prospectus Department, or by email at firstname.lastname@example.org; Jefferies LLC, Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY 10022, by telephone at (877) 821-7388 or by email at Prospectus_Department@Jefferies.com; or Cowen and Company, LLC, c/o Broadridge Financial Services, Attention: Prospectus Department, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at 631-274-2806 or by fax at 631-254-7140.
SOURCE CytomX Therapeutics
We are a well-established biotech company in Sorrento Valley. Our team is in need of a Manufacturing Technician with knowledge of Microbiology.
This will be a long-term opportunity
Monday- Friday, 7 AM- 3:30 PM
The Manufacturing Te […
Aurora Spine Corporation Files Condensed Consolidated Financial Statements for the Six Months Ended June 30, 2015
CARLSBAD, CALIFORNIA–(Marketwired – Aug. 28, 2015) -
Is a fully integrated contract development and manufacturing organization providing clinical drug process development and manufacturing services to global…
From Ajinomoto Althea, Inc. – 28 Aug 2015 19:01:15 GMT
– View all San…
We are working with a North County client in the biotech industry seeking a tenured Accounts Payable Specialist to add to their staff. The roles of the Accounts Payable Specialist will be: – Full cycle accounts payable with 3 way match…
Four University of California, San Diego School of Medicine researchers have been selected to receive the newly established National Cancer Institute (NCI) Outstanding Investigator Award. The multi-million dollar awards fund new projects that have an u…
Title: Clinical Data Manager Company: Pharmaceutical Duration: Permanent Location: San Diego, CA Scope: Supports the Data Management team by managing the
From Planet Pharma – 28 Aug 2015 18:37:05 GMT
– View all San Diego jobs
Argen Corporation is a leading provider of precious dental alloys in the world and innovators in additive manufacturing. We currently have an exciting career opportunity for a chemist to join our assay and refining team.
This position is re […